Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 15 Projects
Project # Contact PI Funding Organization Fiscal Year
Alzheimer's Disease Neuroimaging Initiative (ADNI) 3 - Amyloid PET Early Frames Add-on Study
GC-201810-2017396 Canet-Aviles, Rosa Alzheimer's Drug Discovery Foundation 2019
Alzheimer's Disease Neuroimaging Initiative (ADNI) 3
GC-2013576 Menetski, Joe Alzheimer's Drug Discovery Foundation 2018
Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders
GC-201712-2014401 Upton, Meredith Alzheimer's Drug Discovery Foundation 2018
Resolving the Mechanism of Neuroinflammation for the Innovative Therapy of Neurodegenerative Diseases
EUJPND-SloveniaARRA-Bratkovi-1296 Bratkovi, Iva SLOVENIAN STATE RESEARCH AGENCY (ARRS) 2016
Pathogenic mechanism of the C9orf72 expanded hexanucleotide repeat mutation in neurodegeneration
EUJPND-SloveniaARRA-Rogelj-1297 Rogelj, Boris SLOVENIAN STATE RESEARCH AGENCY (ARRS) 2016
Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
EUJPND-SloveniaARRA-Rogelj-1298 Rogelj, Boris SLOVENIAN STATE RESEARCH AGENCY (ARRS) 2016
Post-transcriptional regulatory networks in neurodegenerative diseases
EUJPND-SloveniaARRA-Ule-1299 Ule, Jernej SLOVENIAN STATE RESEARCH AGENCY (ARRS) 2016
Accelerating Medicines Partnership (AMP) - Alzheimer's Disease formerly the Target Validation Consortium (TVC)
20140502-Wholley-2014 Wholley, David Alzheimer's Drug Discovery Foundation 2014
National Institutional Review Board for Neurodegenerative Diseases
20130902-Knopman-2013 KNOPMAN, DAVID S Alzheimer's Drug Discovery Foundation 2013
Integrative genomic approach to prioritize targets for drug discovery and development in Alzheimer's disease and aging-related cognitive decline
20131208-Pochet-2013 Pochet, Nathalie Alzheimer's Drug Discovery Foundation 2013